Isomerase will attend Bio Innovations Europe 2026, taking place in The Hague, Netherlands, on June 10 - 11. Chief Technology Officer Steven Moss will represent Isomerase at the event, connecting with partners and innovators across the biomanufacturing and industrial biotechnology sectors.
Bio Innovations Europe brings together leading companies, investors, and researchers working in synthetic biology, fermentation, and sustainable manufacturing, providing a platform for collaboration and partnership development.
Meet Isomerase at Bio Innovations Europe
Isomerase is actively seeking to connect with organizations developing, scaling, and de-risking fermentation-based bioprocesses. Areas of interest include:
- Industrial Biotechnology
- Specialty Chemicals
- Food and Ingredients
- Biomaterials
Steven Moss will be available for meetings throughout the conference. Attendees can connect via the event’s 1-2-1 meeting platform or contact
Learn more about the conference here.
Supporting Innovation Through the UK DBT Trade Mission
Isomerase has been selected to participate in the UK Department for Business and Trade (DBT) Engineering Biology Trade Mission to the Netherlands (June 9 - 11, 2026). We are joining eight other innovative UK companies as part of the delegation.
The mission includes targeted networking opportunities and site visits designed to accelerate collaboration and market engagement, with a focus on building partnerships across the Dutch and wider European biomanufacturing landscape.
About Isomerase
Isomerase is an R&D partner specializing in:
- Microbial Strain Engineering
- Enzyme Discovery and Optimisation
- Bioprocess Development
With integrated expertise across biology, chemistry, and bioinformatics, Isomerase supports both end-to-end programs and targeted projects, helping partners develop robust, de-risked and commercially viable biomanufacturing processes